Observational Studies on Evaluating the Safety and Adverse Effects of Traditional Chinese Medicine

Author:

Lai Jung-Nein12,Tang Jin-Ling34,Wang Jung-Der5

Affiliation:

1. Institute of Traditional Medicine, School of Medicine, National Yang-Ming University, Taipei City 112, Taiwan

2. Department of Chinese Medicine, Taipei City Hospital, Yangming Branch, Taipei City 111, Taiwan

3. Center for Evidence Based Medicine, Peking University Health Science Centre, Peking University, Beijing 100871, China

4. Division of Epidemiology, School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong

5. Department of Public Health, College of Medicine, National Cheng Kung University, Tainan City 701, Taiwan

Abstract

Background. This study aims to share our experiences when carrying out observational studies of traditional Chinese medicine (TCM).Methods. We have proactively monitored the safety profiles ofDuhuo Jisheng Tang (DJT),Suan Zao Ren Tang (SZRT), and TMN-1. A list of adverse events (AEs), complete blood counts, and liver and kidney function tests were obtained from the participants during their scheduled hospital visits. Retrospective observational studies were conducted based on the reimbursement database of the National Health Insurance system, Taiwan, to explore the relationship between the use of TCM that have been adulterated by aristolochic acid and the risk from both nephrotoxins and carcinogens.Results. A total of 221, 287, and 203 AEs were detected afterSZRT,DJT, and TMN-1 had been taken, respectively. Dizziness, headache, stomach ache, and diarrhea were judged to be probably related toSZRTtreatment. Retrospective observational studies found an association between the consumption of aristolochic acid-containing Chinese formulae such asMu Tongand an increased risk of CKD, ESRD, and urinary tract cancer.Conclusion.Prospective and retrospectiveobservational studies seem to have specific advantages when investigating the safety and adverse effects of TCM therapies, as well as possibly other alternative/complementary therapies.

Funder

Committee on Chinese Medicine and Pharmacy

Publisher

Hindawi Limited

Subject

Complementary and alternative medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3